1. Efficacy and safety of obinutuzumab combined with fludarabine and cyclophosphamide (FCG) or bendamustine (BG) in relapsed or refractory CLL patients followed by maintenance therapy with obinutuzumab for responding patients. Issue 2 (28th January 2023) Authors: Kutsch, Nadine; Holmes, Emily Eva; Robrecht, Sandra; Schüler, Gudrun; Vehling-Kaiser, Ursula; Decker, Thomas; Müller-Hagen, Sigrun; Heinisch, Karin; Böttcher, Sebastian; Ritgen, Matthias; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Fink, Anna Maria; Fischer, Kirsten; Eichhorst, Barbara; Hallek, M... Journal: Leukemia & lymphoma Issue: Volume 64:Issue 2(2023) Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial. Issue 7 (July 2016) Authors: Eichhorst, Barbara; Fink, Anna-Maria; Bahlo, Jasmin; Busch, Raymonde; Kovacs, Gabor; Maurer, Christian; Lange, Elisabeth; Köppler, Hubert; Kiehl, Michael; Sökler, Martin; Schlag, Rudolf; Vehling-Kaiser, Ursula; Köchling, Georg; Plöger, Christoph; Gregor, Michael; Plesner, Torben; Trneny, Marek; F... Journal: Lancet oncology Issue: Volume 17:Issue 7(2016:Jul.) Page Start: 928 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. Issue 9 (September 2017) Authors: Adams, Richard; Bateman, Andrew; Blesing, Claire; Brown, Ewan; Chau, Ian; Cummins, Sebastian; Cunningham, David; Falk, Stephen; Hadaki, Maher; Hall, Marcia; Hickish, Tamas; Hornbuckle, Joanne; Lofts, Fiona; Lowndes, Sarah; Mayer, Astrid; Metcalfe, Matthew; Middleton, Gary; Mills, Jamie; Montazeri... Journal: Lancet oncology Issue: Volume 18:Issue 9(2017:Sep.) Page Start: 1159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. Issue 9 (September 2017) Authors: Adams, Richard; Bateman, Andrew; Blesing, Claire; Brown, Ewan; Chau, Ian; Cummins, Sebastian; Cunningham, David; Falk, Stephen; Hadaki, Maher; Hall, Marcia; Hickish, Tamas; Hornbuckle, Joanne; Lofts, Fiona; Lowndes, Sarah; Mayer, Astrid; Metcalfe, Matthew; Middleton, Gary; Mills, Jamie; Montazeri... Journal: Lancet oncology Issue: Volume 18:Issue 9(2017:Sep.) Page Start: 1159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial. Issue 10 (October 2016) Authors: Stintzing, Sebastian; Modest, Dominik P; Rossius, Lisa; Lerch, Markus M; von Weikersthal, Ludwig Fischer; Decker, Thomas; Kiani, Alexander; Vehling-Kaiser, Ursula; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Stauch, Martin... Journal: Lancet oncology Issue: Volume 17:Issue 10(2016:Oct.) Page Start: 1426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the 'Arbeitsgemeinschaft Internistische Onkologie' (AIO-PK0104). Issue 5 (7th July 2012) Authors: Heinemann, Volker; Vehling-Kaiser, Ursula; Waldschmidt, Dirk; Kettner, Erika; Märten, Angela; Winkelmann, Cornelia; Klein, Stefan; Kojouharoff, Georgi; Gauler, Thomas C; von Weikersthal, Ludwig Fischer; Clemens, Michael R; Geissler, Michael; Greten, Tim F; Hegewisch-Becker, Susanna; Rubanov, Oleg... Journal: Gut Issue: Volume 62:Issue 5(2013) Page Start: 751 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: A subgroup analysis from AIO-PK0104. (July 2015) Authors: Kruger, Stephan; Boeck, Stefan; Heinemann, Volker; Laubender, Ruediger P.; Vehling-Kaiser, Ursula; Waldschmidt, Dirk; Kettner, Erika; Märten, Angela; Winkelmann, Cornelia; Klein, Stefan; Kojouharoff, Georgi; Gauler, Thomas C.; Fischer von Weikersthal, Ludwig; Clemens, Michael R.; Geissler, Michae... Journal: Acta oncologica Issue: Volume 54:Number 7(2015) Page Start: 993 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG). Issue 1 (February 2020) Authors: Kutsch, Nadine; Bahlo, Jasmin; Robrecht, Sandra; Franklin, Jeremy; Zhang, Can; Maurer, Christian; De Silva, Nisha; Lange, Elisabeth; Weide, Rudolf; Kiehl, Michael G.; Sökler, Martin; Schlag, Rudolf; Vehling-Kaiser, Ursula; Köchling, Georg; Plöger, Christoph; Gregor, Michael; Plesner, Torben; Herl... Journal: HemaSphere Issue: Volume 4:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Low-dose fludarabine with or without darbepoetin alfa in patients with chronic lymphocytic leukemia and comorbidity: primary results of the CLL9 trial of the German CLL Study Group. Issue 3 (3rd March 2016) Authors: Goede, Valentin; Busch, Raymonde; Bahlo, Jasmin; Chataline, Viktoria; Kremers, Stephan; Müller, Lothar; Reschke, Daniel; Schlag, Rudolf; Schmidt, Burkhard; Vehling-Kaiser, Ursula; Wedding, Ulrich; Stilgenbauer, Stefan; Hallek, Michael Journal: Leukemia & lymphoma Issue: Volume 57:Issue 3(2016:Mar.) Page Start: 596 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer. Issue 7 (August 2017) Authors: Stahler, Arndt; Heinemann, Volker; Neumann, Jens; Crispin, Alexander; Schalhorn, Andreas; Stintzing, Sebastian; Giessen-Jung, Clemens; Fischer von Weikersthal, Ludwig; Vehling-Kaiser, Ursula; Stauch, Martina; Quietzsch, Detlef; Holch, Julian W.; Kruger, Stephan; Haas, Michael; Michl, Marlies; von... Journal: Anti-cancer drugs Issue: Volume 28:Issue 7(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗